Skip to content

Released Feb 25, 2019, after the close

10-K filed Feb 25, 2019, 56 days after period end · 0001564590-19-004093

Q4 2018 · 10-K
Revenue$121.08M+3.6% vs Q4 2017+8.4% vs Q3 2018
Net Income$8.87M+465.8% vs Q4 2017N/M vs Q3 2018
EPS Diluted$0.46+475.0% vs Q4 2017N/M vs Q3 2018
Gross Profit$95,452,000+2.3%
Operating Income$12,402,000−30.6%
Operating Cash Flowderived$21,089,000−29.3%
Free Cash Flowderived$17,083,000−35.8%
Margins · derived
Gross margin78.8%−1.0 pt vs Q4 2017
Operating margin10.2%−5.0 pt vs Q4 2017
Net margin7.3%+6.0 pt vs Q4 2017

What the release said

The release

Same quarter

MetricQ4 2018Q4 2017Q4 2016Q4 2015
Revenue$121.08M$116.90M$108.54M$104.62M
Net Income$8.87M$1.57M-$3.24M$3.37M
EPS Diluted$0.46$0.08-$0.18$0.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR